Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar.
CADTH Health Technology Assessments.

Excerpt

The objective of this review is to assess the benefits and harms of drugs used in adult patients with moderate to severe rheumatoid arthritis (RA) in whom treatment with methotrexate (MTX) has failed or who are intolerant to MTX.

Publication types

  • Review

Grants and funding

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.